+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

ACP Journal Club. Concomitant use of proton pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI



ACP Journal Club. Concomitant use of proton pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI



Annals of Internal Medicine 151(4): Jc2-J13




(PDF emailed within 0-6 h: $19.90)

Accession: 051291173

Download citation: RISBibTeXText

PMID: 19687487

DOI: 10.7326/0003-4819-151-4-200908180-02013


Related references

Concomitant use of proton pump inhibitors with clopidogrel may increase risk of readmission after discharge for acute MI. Evidence-Based Medicine 14(5): 154-154, 2009

ACP Journal Club. Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MI. Annals of Internal Medicine 153(12): Jc6-J13, 2010

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 301(9): 937-944, 2009

Frequency and outcomes of concomitant use of proton pump inhibitors and clopidogrel after hospital discharge. Therapie 68(2): 113-115, 2013

Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors. Alimentary Pharmacology & Therapeutics 33(1): 77-88, 2011

Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors. Expert Opinion on Drug Safety 11(2): 275-284, 2012

Risk of adverse clinical outcomes with concomitant use of clopidogrel and proton pump inhibitors following percutaneous coronary intervention. Digestive Diseases and Sciences 55(7): 1964-1968, 2010

Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients. Current Medical Research and Opinion 29(4): 315-323, 2013

ACP Journal Club: review: proton-pump inhibitors are associated with increased risk for Clostridium difficile infection. Annals of Internal Medicine 157(4): Jc2-J13, 2012

Cardiovascular Outcomes Associated with Concomitant Use of Clopidogrel and Proton Pump Inhibitors in Patients of Acute Coronary Syndrome in Taiwan. 2012

Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan. British Journal of Clinical Pharmacology 74(5): 824-834, 2013

Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding. Bmc Pharmacology & Toxicology 15(): 22-22, 2014

Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome. Journal of Geriatric Cardiology 13(3): 209-217, 2016

Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention. American Journal of Cardiology 105(12): 1705-1709, 2010

Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel. American Journal of Cardiology 117(3): 366-368, 2016